Maghazachi A A, Goldfarb R H, Herberman R B
Pittsburgh Cancer Institute, PA.
J Immunol. 1988 Dec 1;141(11):4039-46.
Lymphokine-activated killer (LAK) cells are currently being evaluated in several cancer centers for the immunotherapy of patients with a variety of cancers. Understanding the in vivo distribution of LAK cells should help to optimize their antitumor efficacy. As a model system to examine this issue, nylon wool column-passed rat lymphocytes were cultured in the presence of rIL-2 for 1 and 2 days. The resulting cells were divided into two populations; one that adhered to the plastic flasks and the second which did not adhere. The adherent cells were found to be highly cytotoxic against NK-sensitive and NK-resistant targets, whereas the nonadherent cells were unable to kill NK-resistant targets unless T cells were removed from this population. These results indicate that T cells present in IL-2 activated bulk splenocytes may interfere with the activity of LAK cells. Adherent or nonadherent LAK cells were evaluated for their pattern of in vivo distribution after i.v. inoculation. These cells were found to display a restricted pattern of distribution, localizing mainly in the lungs at 2 h after i.v. injection but redistributing into the liver and the spleen by 24 h. LAK cells were rarely recovered from the lymphoid tissues, including the peripheral lymph nodes and the mesenteric lymph nodes. However, if T cells were not removed from the LAK cell population, some radioactivity was recovered from the peripheral and mesenteric lymph nodes. Fractionation of 2 day-activated, nonadherent population on discontinuous Percoll resulted in the enrichment of large granular lymphocyte (LGL)/LAK activity in low density fractions (42% and 45% Percoll), whereas high density fraction (70% Percoll) contained T cells which showed no cytolytic activity. Upon transfer into syngeneic rats, the 42% fraction showed typical LAK migration. In contrast, the 70% fraction showed typical T cell migration. What is more important, removal of the granulated cells resulted in a population which have no granules and resemble large agranular lymphocytes known to be pre-LGL/LAK cells. Large agranular lymphocytes showed a pattern of distribution different from both T and LGL/LAK cells.
淋巴因子激活的杀伤(LAK)细胞目前正在多个癌症中心接受评估,用于多种癌症患者的免疫治疗。了解LAK细胞在体内的分布情况应有助于优化其抗肿瘤疗效。作为研究此问题的模型系统,将通过尼龙毛柱的大鼠淋巴细胞在重组白细胞介素-2(rIL-2)存在的情况下培养1天和2天。所得细胞分为两个群体;一个群体粘附于塑料培养瓶,另一个群体不粘附。发现粘附细胞对自然杀伤(NK)敏感和NK抗性靶标具有高度细胞毒性,而非粘附细胞除非从该群体中去除T细胞,否则无法杀死NK抗性靶标。这些结果表明,存在于IL-2激活的大量脾细胞中的T细胞可能会干扰LAK细胞的活性。静脉注射后,评估粘附或非粘附LAK细胞的体内分布模式。发现这些细胞呈现出受限的分布模式,静脉注射后2小时主要定位于肺部,但到24小时时重新分布到肝脏和脾脏。LAK细胞很少从包括外周淋巴结和肠系膜淋巴结在内的淋巴组织中回收。然而,如果不从LAK细胞群体中去除T细胞,则会从外周和肠系膜淋巴结中回收一些放射性物质。对2天激活的非粘附群体进行不连续 Percoll 分级分离,导致低密度级分(42%和45% Percoll)中富含大颗粒淋巴细胞(LGL)/LAK活性,而高密度级分(70% Percoll)含有无细胞溶解活性的T细胞。转移到同基因大鼠后,42%级分显示出典型的LAK迁移。相比之下,70%级分显示出典型的T细胞迁移。更重要的是,去除颗粒细胞后得到的群体没有颗粒,类似于已知为前LGL/LAK细胞的大颗粒淋巴细胞。大颗粒淋巴细胞呈现出与T细胞和LGL/LAK细胞都不同的分布模式。